Cerence/ US1567271093 /
20/05/2024 21:59:58 | Var. -0.05 | Volume | Denaro- | Lettera- | Max | Min |
---|---|---|---|---|---|---|
3.93USD | -1.26% | 82,789 Fatturato: 326,722.62 |
-Quantità in denaro: - | -Quantità in lettera: - | 4.07 | 3.86 |
GlobeNewswire
14:46
Videra Health Secures 5.6M in Funding to Advance Mental Health AI Solutions Led by Peterson Ventures
GlobeNewswire
14:45
Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Ph...
GlobeNewswire
14:45
StraighterLine, CCEI and American College of Education Team Up to Offer Early Childhood Educators Pa...
GlobeNewswire
14:45
Global Sports Nutrition Market Projected to Reach $78 Billion as Muscle Repair & Growth Becoming Vit...
GlobeNewswire
14:45
Silo Pharma Announces Positive Results from Study for Depression Treatment, Remission, and Relapse P...
GlobeNewswire
14:40
Navios Maritime Holdings Inc. Provides Important Reminder for All Holders of Series G And Series H A...
GlobeNewswire
14:35
Legendary Music Executive Jerry Greenberg & Joy Peters Partner With Brian J. Esposito, CEO Of Esposi...
GlobeNewswire
14:35
GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for t...
GlobeNewswire
14:35
NNN REIT, Inc. (NYSE:NNN) President and CEO Steve Horn Interviewed by Advisor Access
GlobeNewswire
14:31
Alliance Entertainment’s Distribution Solutions Extends Partnership with Cineverse
GlobeNewswire
14:31
C-Bond Systems’ Ballistic-Resistant System Achieves National Institute of Justice Level III Certific...
GlobeNewswire
14:31
Reborn Coffee Announces Letter of Intent to Acquire Majority Stake in Derin Lezzetler, an Istanbul, ...
GlobeNewswire
14:30
Earlyworks Co., Ltd., a blockchain technology provider, forms business alliance with Relic, a busine...
Newsfile Corp
14:30
Kenorland Arranges Strategic Investment by Centerra Gold Through C$9.86M Non-Brokered Private Placem...
Newsfile Corp
14:30
PurMinds Chief Scientific Officer to Speak at the 4th Annual Psychedelic Therapeutics and Drug Devel...